Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment in Patients with MIBC and Response Can Be Monitored by ctDNA By Ogkologos - March 12, 2026 141 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INDIBLADE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR How to Talk About Advanced Cancer Care Planning: An Expert Discussion November 20, 2023 What Caregivers Should Know About End-of-Life Care Issues for People With... September 8, 2022 Lawmaker Dad Raises Awareness For RSV, An Illness He’d Never Heard... November 20, 2019 FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who... March 20, 2025 Load more HOT NEWS Cancer research could revive the UK’s ailing public finances Terminally Ill ‘Flamingo Lady’ Gets Emotional After Dying Wish Comes True Mental Health Awareness for Health Care Providers Cancer in children and young people: how far we’ve come
